CTS2190 Phase I /II Clinical Study in Patients
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Solid Tumors|Pancreatic Cancer|Non-small Cell Lung Cancer|Triple-negative Breast Cancer
Interventions: DRUG: CTS2190 capsules
Sponsor: CytosinLab Therapeutics Co., Ltd.